American Sleep Association. Restless legs syndrome. Accessed December 8, 2016.

Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. SLEEP. 2010;33(1):81-87.

GarcĂ­a-Borreguero D, Williams A-M. Dopaminergic augmentation of restless legs syndrome. Sleep Med Rev. 2010;14(5):339-346.

International Restless Legs Syndrome Study Group. White paper summary of recommendations for the prevention and treatment of RLS/WED augmentation: a combined task force of the IRLSSG, EURLSSG and the RLS-Foundation. Updated August 13, 2015. Accessed December 30, 2016.

Liu GJ, Wu L, Wang SL, et al. Incidence of augmentation in primary restless legs syndrome patients may not be that high: evidence from a systematic review and meta-analysis. Medicine. 2016;95(2):e2504. doi:10.1097/MD.0000000000002504.

National Institute of Neurological Disorders and Stroke. Restless legs syndrome fact sheet. Accessed November 21, 2016.

Restless Legs Syndrome Foundation. Restless legs syndrome: causes, diagnosis and treatment for the patient living with restless legs syndrome (RLS). Accessed November 21, 2016.

Restless Legs Syndrome Foundation. Understanding Augmentation and Restless Legs Syndrome. Austin, TX: Restless Legs Syndrome Foundation; 2015.

Restless Legs Syndrome Foundation. What is augmentation? Accessed November 21, 2016.